Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Short Candidates -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (163)	12/31/2001 8:15:21 PM
From: tuck	Read Replies (2) \| Respond to of 897

Rick, Wilder, and All, I don't think IMCL got whacked hard enough, and it's in the WatchList now. BTW, someone on the IMCL thread said there was a patent challenge coming from ABGX. I thought it was from DNA. Could there be two challenges coming? Don't know why I waited to pull the trigger on AMGN. Scared by seasonality, I guess. I think I will soon, and on IMCL, too. Which I liked two years ago until it got beyond $30, but didn't dare reenter for reasons better expressed by V1. I actually looked at TXBI and was about to post some stuff when the PC froze and I lost it. Then Rick said he wasn't serious. But it would have been a good trading call. Any studies on the therapeutic value of champagne? No wait, we'd best not get started, but . . . Happy New Years, All! Cheers, Tuck